Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP614603.RA3PVkrJCwGRKdS15nAiV-ZjbMFlC09Gabl7Vq1XHRiqk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP614603.RA3PVkrJCwGRKdS15nAiV-ZjbMFlC09Gabl7Vq1XHRiqk130_assertion type Assertion NP614603.RA3PVkrJCwGRKdS15nAiV-ZjbMFlC09Gabl7Vq1XHRiqk130_head.
- NP614603.RA3PVkrJCwGRKdS15nAiV-ZjbMFlC09Gabl7Vq1XHRiqk130_assertion description "[ETA R antagonism with atrasentan reduced cell proliferation by 16% in papillary carcinoma cells (P < 0.05) and by 51% in follicular carcinoma cells (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614603.RA3PVkrJCwGRKdS15nAiV-ZjbMFlC09Gabl7Vq1XHRiqk130_provenance.
- NP614603.RA3PVkrJCwGRKdS15nAiV-ZjbMFlC09Gabl7Vq1XHRiqk130_assertion evidence source_evidence_literature NP614603.RA3PVkrJCwGRKdS15nAiV-ZjbMFlC09Gabl7Vq1XHRiqk130_provenance.
- NP614603.RA3PVkrJCwGRKdS15nAiV-ZjbMFlC09Gabl7Vq1XHRiqk130_assertion SIO_000772 17561979 NP614603.RA3PVkrJCwGRKdS15nAiV-ZjbMFlC09Gabl7Vq1XHRiqk130_provenance.
- NP614603.RA3PVkrJCwGRKdS15nAiV-ZjbMFlC09Gabl7Vq1XHRiqk130_assertion wasDerivedFrom befree-2016 NP614603.RA3PVkrJCwGRKdS15nAiV-ZjbMFlC09Gabl7Vq1XHRiqk130_provenance.
- NP614603.RA3PVkrJCwGRKdS15nAiV-ZjbMFlC09Gabl7Vq1XHRiqk130_assertion wasGeneratedBy ECO_0000203 NP614603.RA3PVkrJCwGRKdS15nAiV-ZjbMFlC09Gabl7Vq1XHRiqk130_provenance.